Murray B. Resnick

9.6k citations

174 papers · 6.7k indexed · h-index 44

Impact in

Oncology top 1%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
Cancer Research top 1%
- Cancer-related molecular mechanisms research

Papers in

Oncology 59
- Colorectal Cancer Treatments and Studies 14
- Colorectal Cancer Screening and Detection 10
Pathology and Forensic Medicine 32
- Genetic factors in colorectal cancer 23

Co-authors: Edmond Sabo Evgeny Yakirevich Peter F. Weller Tamako Konkin Lelia Noble Ronald A. DeLellis Rosemarie Tavares Victor E. Pricolo
Journals: Human Pathology (19 papers)Clinical Cancer Research (10 papers)Modern Pathology (8 papers)Applied immunohistochemistry & molecular morphology (7 papers)Journal of Hepatology (7 papers)
Partner nations: United States Israel Canada

In The Last Decade

Murray B. Resnick

172 papers receiving 6.6k citations

Peers

Countries citing papers authored by Murray B. Resnick

Since Specialization

Citations

This map shows the geographic impact of Murray B. Resnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray B. Resnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray B. Resnick more than expected).

Fields of papers citing papers by Murray B. Resnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray B. Resnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray B. Resnick. The network helps show where Murray B. Resnick may publish in the future.

Co-authors

The 25 scholars most cited alongside Murray B. Resnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Murray B. Resnick Line = papers co-authored together Murray B. Resnick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study Hepatology Communications ·Arun J. Sanyal, Rohit Loomba, Quentin M. Anstee, Vlad Ratziu, Kris V. Kowdley, Mary E. Rinella, Stephen Harrison, Murray B. Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M. Younossi	2023	7
2	Somatic mutations in collagens are associated with a distinct tumor environment and overall survival in gastric cancer BMC Cancer ·Alexander S. Brodsky, Jay Khurana, Kevin S. Guo, Elizabeth Y. Wu, Dongfang Yang, Ayesha Siddique, Ian Y. Wong, Ece D. Gamsiz Uzun, Murray B. Resnick	2022	12
3	Analysis of POLE mutation and tumor mutational burden (TMB) across 80,853 tumors: Implications for immune checkpoint inhibitors (ICPIs) Annals of Oncology ·Alexa B. Schrock, David Fabrizio, Yuxia He, John W. Chung, Murray B. Resnick, Philip J. Stephens, Jeffrey S. Ross, V.A. Miller, S. Ramkissoon, J.A. Elvin, Siraj M. Ali, Marwan Fakih, Samuel J. Klempner	2017	11
4	Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target Clinical Cancer Research ·Evgeny Yakirevich, Murray B. Resnick, Shamlal Mangray, Michael B. Wheeler, Cynthia L. Jackson, Kara A. Lombardo, Jeeyun Lee, Kyoung‐Mee Kim, Anthony J. Gill, Kai Wang, Kyle Gowen, James Sun, Vincent A. Miller, Philip J. Stephens, Siraj M. Ali, Jeffrey S. Ross, Howard Safran	2016	88
5	Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer BMC Cancer ·Alexander S. Brodsky, Jinjun Xiong, Dongfang Yang, Christoph Schorl, Mary Anne Fenton, Theresa A. Graves, William M. Sikov, Murray B. Resnick, Yihong Wang	2016	38
6	Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway Modern Pathology ·Stephanie Wood, Anthony J. Gill, Alexander S. Brodsky, Shaolei Lu, Kenneth Friedman, Galina Karashchuk, Kara A. Lombardo, Dongfang Yang, Murray B. Resnick	2016	17
7	Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment Modern Pathology ·Kenneth Friedman, Alexander S. Brodsky, Shaolei Lu, Stephanie Wood, Anthony J. Gill, Kara A. Lombardo, Dongfang Yang, Murray B. Resnick	2016	62
8	Cadherin 17 Is a Sensitive and Specific Marker for Metanephric Adenoma The American Journal of Surgical Pathology ·Evgeny Yakirevich, Cristina Magi‐Galluzzi, Zakaria Grada, Shaolei Lu, Murray B. Resnick, Shamlal Mangray	2015	10
9	Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study Clinical Cancer Research ·Daniel J. Sargent, Qian Shi, Sharlene Gill, Christophe Louvet, Richard B. Everson, Udo Kellner, Thomas E. Clancy, J. Marc Pipas, Murray B. Resnick, Michael O. Meyers, Tsung‐Teh Wu, David G. Huntsman, Pierre Validire, Umar Farooq, Emily S. Pavey, Guillaume Beaudry, Jean-François Haince, Yves Fradet	2014	8
10	Intra-operative microwave ablation of liver malignancies with tumour permittivity feedback control: a prospective ablate and resect study HPB ·Linda Ratanaprasatporn, Kevin P. Charpentier, Murray B. Resnick, Shaolei Lu, Damian E. Dupuy	2013	13
11	Evaluation of Guanylyl Cyclase C Lymph Node Status for Colon Cancer Staging and Prognosis Annals of Surgical Oncology ·Daniel J. Sargent, Murray B. Resnick, Michael O. Meyers, Atoussa Goldar‐Najafi, Thomas E. Clancy, Sharlene Gill, Gary O. Siemons, Qian Shi, Brian M. Bot, Tsung‐Teh Wu, Guillaume Beaudry, Jean-François Haince, Yves Fradet	2011	26
12	Irreversible electroporation of the liver and liver hilum in swine HPB ·Kevin P. Charpentier, Farrah J. Wolf, Lelia Noble, Brody Winn, Murray B. Resnick, Damian E. Dupuy	2011	133
13	Bile Acid Reflux Contributes to Development of Esophageal Adenocarcinoma via Activation of Phosphatidylinositol-Specific Phospholipase Cγ2 and NADPH Oxidase NOX5-S Cancer Research ·Jie Hong, José Behar, Jack R. Wands, Murray B. Resnick, Lijuan Wang, Ronald A. DeLellis, David Lambeth, Weibiao Cao	2010	32
14	GCDFP-15 Positive and TTF-1 Negative Primary Lung Neoplasms Applied immunohistochemistry & molecular morphology ·Li‐Ju Wang, Wesley O. Greaves, Edmond Sabo, Lelia Noble, Rosemarie Tavares, Thomas Ng, Ronald A. DeLellis, Murray B. Resnick	2009	27
15	Expression Analysis of Barrett's Esophagus–Associated High-Grade Dysplasia in Laser Capture Microdissected Archival Tissue Clinical Cancer Research ·Edmond Sabo, Patricia A. Meitner, Rosemarie Tavares, Christopher L. Corless, Gregory Y. Lauwers, Steven F. Moss, Murray B. Resnick	2008	26
16	Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation Human Pathology ·Brody Winn, Rosemarie Tavares, Jacqueline Fanion, Lelia Noble, John Gao, Edmond Sabo, Murray B. Resnick	2008	68
17	Analysis of T-Cell Clonality Using Laser Capture Microdissection and High-Resolution Microcapillary Electrophoresis Journal of Molecular Diagnostics ·Evgeny Yakirevich, Cynthia L. Jackson, Patricia A. Meitner, Dolores MacKenzie, Rose Tavares, Leslie Robinson‐Bostom, Ronald A. DeLellis, Murray B. Resnick	2007	14
18	Nuclear localization of long-VEGF is associated with hypoxia and tumor angiogenesis Biochemical and Biophysical Research Communications ·Yifat Rosenbaum-Dekel, Alisa Fuchs, Evgeny Yakirevich, Aviva Azriel, Salam Mazareb, Murray B. Resnick, Ben-Zion Levi	2005	30
19	Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia Human Pathology ·Murray B. Resnick, Susan C. Lester, James E. Tate, Ellen E. Sheets, Caroline A. Sparks, C. Crum	1996	49
20	Reduction of tellurite and deesterification of fluorescein diacetate are not well correlated with the viability of mycobacteria Annales de l Institut Pasteur Microbiologie ·N Mor, Murray B. Resnick, Fauzi S. Silbaq, Hervé Bercovier, L Lévy	1988	8

About Murray B. Resnick

Murray B. Resnick is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Surgery and Immunology, having authored 174 papers that have together received 6.7k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (23 papers), Eosinophilic Esophagitis (15 papers), Colorectal Cancer Treatments and Studies (14 papers), Eosinophilic Disorders and Syndromes (13 papers), Helicobacter pylori-related gastroenterology studies (11 papers), Colorectal Cancer Screening and Detection (10 papers), Esophageal Cancer Research and Treatment (9 papers) and Gastric Cancer Management and Outcomes (9 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.1k citations), Immunology (1.2k citations), Immunology and Allergy (316 citations) and Neurology (399 citations). Murray B. Resnick has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Edmond Sabo, Evgeny Yakirevich, Peter F. Weller, Tamako Konkin, Lelia Noble, Ronald A. DeLellis, Rosemarie Tavares, Victor E. Pricolo, Steven F. Moss and Jack R. Wands. Their work appears in journals such as Human Pathology, Clinical Cancer Research, Modern Pathology, Applied immunohistochemistry & molecular morphology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact